Arkolith/Insider Trading/IONS/Form 4

Loscalzo Joseph

DirectorIONIS PHARMACEUTICALS INC (IONS) · full profile →Form 4 · filed May 6, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$5.8M
Net Open-Market Flow
-$5.8M
Transactions
14
8 non-derivative · 6 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 4, 2026Option exercise(M)11K$38.06$417K47K
May 4, 2026Option exercise(M)12K$40.05$481K59K
May 4, 2026Option exercise(M)10K$41.08$424K70K
May 4, 2026Option exercise(M)16K$42.88$686K86K
May 4, 2026Option exercise(M)12K$60.20$722K98K
May 4, 2026Option exercise(M)16K$64.80$1.0M114K
May 4, 2026Sell(S)60K$74.90$4.5M54K
May 4, 2026Sell(S)18K$75.58$1.3M36K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 4, 2026Option exercise(M)11K—$00
May 4, 2026Option exercise(M)12K—$00
May 4, 2026Option exercise(M)10K—$00
May 4, 2026Option exercise(M)16K—$00
May 4, 2026Option exercise(M)12K—$00
May 4, 2026Option exercise(M)16K—$00

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000874015-26-000183) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML